Literature DB >> 2022575

Carbohydrate metabolism during intense exercise when hyperglycemic.

E F Coyle1, M T Hamilton, J G Alonso, S J Montain, J L Ivy.   

Abstract

The effects of hyperglycemia on muscle glycogen use and carbohydrate metabolism were evaluated in eight well-trained cyclists (average maximal O2 consumption 4.5 +/- 0.1 l/min) during 2 h of exercise at 73 +/- 2% of maximal O2 consumption. During the control trial (CT), plasma glucose concentration averaged 4.2 +/- 0.2 mM and plasma insulin remained between 6 and 9 microU/ml. During the hyperglycemic trial (HT), 20 g of glucose were infused intravenously after 8 min of exercise, after which a variable-rate infusion of 18% glucose was used to maintain plasma glucose at 10.8 +/- 0.4 mM throughout exercise. Plasma insulin remained low during the 1st h of HT, yet it increased significantly (to 16-24 microU/ml; P less than 0.05) during the 2nd h. The amount of muscle glycogen utilized in the vastus lateralis during exercise was similar during HT and CT (75 +/- 8 and 76 +/- 7 mmol/kg, respectively). As exercise duration increased, carbohydrate oxidation declined during CT but increased during HT. Consequently, after 2 h of exercise, carbohydrate oxidation was 40% higher during HT than during CT (P less than 0.01). The rate of glucose infusion required to maintain hyperglycemia (10 mM) remained very stable at 1.6 +/- 0.1 g/min during the 1st h. However, during the 2nd h of exercise, the rate of glucose infusion increased (P less than 0.01) to 2.6 +/- 0.1 g/min (37 mg.kg body wt-1.min-1) during the final 20 min of exercise. We conclude that hyperglycemia (i.e., 10 mM) in humans does not alter muscle glycogen use during 2 h of intense cycling.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022575     DOI: 10.1152/jappl.1991.70.2.834

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  17 in total

Review 1.  Carbohydrate administration and exercise performance: what are the potential mechanisms involved?

Authors:  Antony D Karelis; Johneric W Smith; Dennis H Passe; Francois Péronnet
Journal:  Sports Med       Date:  2010-09-01       Impact factor: 11.136

2.  Exercise, hypoglycemia, and type 1 diabetes.

Authors:  Rita Basu; Matthew L Johnson; Yogish C Kudva; Ananda Basu
Journal:  Diabetes Technol Ther       Date:  2014-05-08       Impact factor: 6.118

3.  Influence of carbohydrate-electrolyte drinks on marathon running performance.

Authors:  O K Tsintzas; C Williams; R Singh; W Wilson; J Burrin
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

Review 4.  Carbohydrate nutrition and fatigue.

Authors:  D L Costill; M Hargreaves
Journal:  Sports Med       Date:  1992-02       Impact factor: 11.136

Review 5.  Human muscle glycogen metabolism during exercise. Effect of carbohydrate supplementation.

Authors:  K Tsintzas; C Williams
Journal:  Sports Med       Date:  1998-01       Impact factor: 11.136

6.  Plasma catecholamines and hyperglycaemia influence thermoregulation in man during prolonged exercise in the heat.

Authors:  R Mora-Rodríguez; J González-Alonso; P R Below; E F Coyle
Journal:  J Physiol       Date:  1996-03-01       Impact factor: 5.182

7.  Carbohydrate supplementation stabilises plasma sodium during training with high intensity.

Authors:  M Schrader; B Treff; T Sandholtet; N Maassen; V Shushakov; J Kaesebieter; M Maassen
Journal:  Eur J Appl Physiol       Date:  2016-07-27       Impact factor: 3.078

8.  Fluid provision and metabolic responses to soccer-specific exercise.

Authors:  N D Clarke; B Drust; D P M Maclaren; T Reilly
Journal:  Eur J Appl Physiol       Date:  2008-09-10       Impact factor: 3.078

9.  Glucose kinetics during prolonged exercise in euglycaemic and hyperglycaemic subjects.

Authors:  J A Hawley; A N Bosch; S M Weltan; S C Dennis; T D Noakes
Journal:  Pflugers Arch       Date:  1994-03       Impact factor: 3.657

10.  Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with type 1 diabetes mellitus--a prospective single-blinded randomised crossover trial.

Authors:  S Jenni; C Oetliker; S Allemann; M Ith; L Tappy; S Wuerth; A Egger; C Boesch; Ph Schneiter; P Diem; E Christ; C Stettler
Journal:  Diabetologia       Date:  2008-05-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.